Loading clinical trials...
Loading clinical trials...
Treatment of Medication-overuse Headache: 4 Years Follow up
From 1 January 2004 to 31 December 2006 64 individuals with probable medication overuse headache were included in a randomized, 1-year open-labeled, multicentre study to evaluate the effect of early introduction of prophylactic treatment compared to abrupt withdrawal and with a control group (ClinicalTrials.gov number NCT00159588). In this follow-up, randomized patients still alive 4 years after primary inclusion time will be invited to a follow up interview, evaluating the headache complaints and the proportion of recurrent medication overuse.
The participants will be interviewed by telephone or consult the study doctor completing a headache diary for at least 1 month before attending the visit.
Age
22 - 74 years
Sex
ALL
Healthy Volunteers
No
Norwegian National headache Centre, NTNU
Trondheim, Norway
Start Date
January 1, 2008
Primary Completion Date
May 1, 2010
Completion Date
May 1, 2010
Last Updated
December 2, 2020
60
ACTUAL participants
No new specific intervention
OTHER
Lead Sponsor
Norwegian University of Science and Technology
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04336267